Editorial introductions : Current Opinion in Clinical Nutrition & Metabolic Care

Journal Logo


Editorial introductions

Editor(s): Calder, Philip C.; Harris, William; Casaer, Michael P.; Deane, Adam

Current Opinion in Clinical Nutrition and Metabolic Care 26(2):p vi-vii, March 2023. | DOI: 10.1097/MCO.0000000000000915
  • Free

Current Opinion in Clinical Nutrition and Metabolic Care was launched in 1998. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of clinical nutrition and metabolic care are divided into 12 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue.


Philip C. Calder

Philip C. Calder

Philip C. Calder is Professor of Nutritional Immunology within the School of Human Development and Health in the Faculty of Medicine at the University of Southampton, UK. He has a PhD in Biochemistry from University of Auckland, New Zealand, and a DPhil in Biochemistry from the University of Oxford, UK. He is a registered nutritionist and a fellow of both the Royal Society of Biology and the Association for Nutrition. He spent four years as a Nuffield Medical Fellow in the Department of Biochemistry at the University of Oxford (1987–1991), followed by four years as a Lecturer in Biochemistry in that same department (1991–1995). In 1995, he took a lectureship at the University of Southampton where he was subsequently appointed to a readership in human nutrition in 1998 and then to a personal chair in nutritional immunology in 2002. For over 30 years he has conducted research on the metabolism and functionality of fatty acids with an emphasis on the roles of omega-3 fatty acids in immunity, inflammation and cardiometabolic disease.

He has received several awards for his work including the Sir David Cuthbertson Medal (1995), the Belgian Danone Institute Chair (2004), the Nutricia International Award (2007), the ESPEN Cuthbertson Lecture (2008), the Muriel Bell Award (2009), the Louisiana State University Chancellor's Award in Neuroscience and Medicine (2011), the Normann Medal from the German Society for Fat Science (2012), the Ralph Holman Lifetime Achievement Award from the American Oil Chemists’ Society (2015), the British Association for Parenteral & Enteral Nutrition's Pennington Lecture (2015), the British Nutrition Foundation Prize (2015), the Danone International Prize for Nutrition (2016), the DSM Lifetime Achievement Award in Nutritional Sciences (2017) and the EuroFed Lipid Lipid Scientist Award (2021).

He has served on many committees of professional societies, including as President of the International Society for the Study of Fatty Acids and Lipids (2009–2012), Chair of the Scientific Committee of the European Society for Clinical Nutrition and Metabolism (ESPEN) (2014–2016) and President of the Nutrition Society (2016–2019). He is currently President of the Federation of European Nutrition Societies. Professor Calder was Editor-in-Chief of the British Journal of Nutrition from 2006 to 2013 and he is currently an Associate Editor of Clinical Science, Journal of Nutrition, Nutrition Research and Annals of Nutrition and Metabolism. He is a member of the several other Editorial Boards of journals in the nutrition, clinical science and lipidology fields. He is listed as a Highly Cited Researcher.

William Harris

William Harris

Dr William Harris obtained a PhD in nutritional biochemistry from the University of Minnesota, USA, in 1978, and did post-doctoral research in lipid metabolism and clinical nutrition under Dr William Connor at the Oregon Health Sciences University USA, between 1978 and 1983. He then served as the Director of the Lipid Research Laboratories at the University of Kansas Medical Center (KUMC), USA, and at the Mid America Heart Institute, USA, for 22 years; during this time, he was on the faculty at KUMC and at the University of Missouri-Kansas City School of Medicine, USA.

In 2006 he moved to Sioux Falls, SD, where he became the first director of the Cardiovascular Health Research Center at Sanford Research/University of South Dakota (USD), USA. He is currently a Professor in the Department of Internal Medicine at the Sanford School of Medicine at USD. Over the last 40 years, Dr Harris's research has focused primarily on understanding the role of omega-3 fatty acids in lowering risk for cardiovascular disease. He has been the principal investigator on five omega-3 related NIH grants and currently has over 330 omega-3-related publications. Dr Harris was a co-author on three American Heart Association Advisory Statements on omega-3 (and omega-6) fatty acids and heart health. In 2004 he and his colleague Clemens von Schacky, MD, developed (and continue to validate) the “Omega-3 Index” (erythrocyte EPA+DHA) as a new risk factor for cardiovascular (and perhaps neurocognitive) disorders.

In 2008, Dr Harris established OmegaQuant Analytics, LLC to offer fatty acid testing services to researchers, healthcare providers and consumers, and in 2020, he founded the Fatty Acid Research Institute, USA, a non-profit entity to foster research on the connections between fatty acids and health. He has been elected a Fellow of the American Heart Association, the National Lipid Association, and the American Society of Nutrition. His scientific productivity was ranked among the top 2% in a 2021 survey of scientists worldwide.

Michael P. Casaer

Michael P. Casaer

Michael P. Casaer is Professor at the Faculty of Medicine KU Leuven, Belgium, and ICU & Burn-Centre Consultant at the Leuven University Hospitals, UZ Leuven, Belgium. His research, teaching and clinical expertise focusses on nutrition, major infectious and traumatic skin and soft tissue lesions, trauma and mass-casualty management and methodology of clinical research in critical illness. He graduated cum laude in medical sciences at KU Leuven in 1996, and is a board-certified anaesthesiologist after training in ZOL, Genk Limburg and Leuven University Hospitals (1996–2001). Dr Casaer was an anaesthesiologist-instructor for Doctors Without Borders in Hôpital Saint Nicolas in Saint Marc, Haiti, in 2001–2002. Thereafter, Dr Casaer joined the Leuven University Hospitals Clinical Department and Laboratory of Intensive Care Medicine, directed initially by Professor Peter Lauwers, thereafter by Professor Greet Van den Berghe. In 2006, Michael was Board Certified Intensive Care Medicine Specialist. During his medical studies and specialization, he enjoyed a lab-rotation in the WARICH, Perth, West-Australia, clinical training in the department of Obstetrics & Gynecology in the Hôpital Régional de Sion, Switzerland, and clinical internship at Shriners Pediatric Burn Hospital, Galveston, Texas, USA, August–September 2005. He qualified as an American Burn Association Advanced Burn Life Support Provider and Instructor in 2005, Medical Statistics at the KU Leuven Faculty of Medicine 2006–2007 and Good Clinical Practice in Clinical Research, UZLeuven 2012.

Dr Casaer has a PhD in Biomedical Sciences. A large RCT evaluating the impact of early versus late parenteral nutrition in critically ill adults was part of his doctoral research project. It included muscle biochemistry and histology, computer tomography and physical function testing, allowing to unravel the mechanisms behind delayed recovery by enhanced early feeding. This doctoral research was endorsed by a grant from the Research Foundation, Flanders, Belgium. Professor Casaer's current research involves novel nutrition strategies aimed at activating autophagy in the critically ill while feeding, identification of the optimum time-point for initiation of artificial nutrition in the ICU and prevention, detection and treatment of micronutrient abnormalities in critical illness. Other ongoing clinical research projects include virtual reality reducing pain and fear during wound care and validated quantification of nurse workload in the ICU.

Prof. Casaer was awarded the 2007 EBA PAM award, the 2007 International Research award “Prix Martin Ramelot” and the 2009 “International Stoutenbeek Award”. He obtained post-doctoral research funding from the Research Foundation Flanders, Belgium, and a C2-Project Grant from the KULeuven. The Virtual Reality in Wound care project 2019–2021 is endorsed by the Ministry of Innovation, Flanders Government, Belgium.

Prof. Casaer is Past-President and board member of the Belgian Association for Burn Injury, Board member of the Leuven University Medical Development Collaboration (active in Cameroon, Benin, DRCongo and Rwanda), and member of the Ethical Committee at UZLeuven. He is member of the Evaluation Committee for Clinical Academical Personnel, Department of Biomedical Sciences, KULeuven. Within the European Society of Intensive Care Medicine, section for Metabolism, Endocrinology and Nutrition, Michael chairs the working group on micronutrients, and he participates in the trauma and emergency medicine section. He was co-author in the European Society of Enteral and Parenteral Nutrition Guideline-writing-Panel for “Nutrition in critical illness” (2016–2018) and for Micronutrients (2019–2021). Prof. Casaer is reviewer for several journals in critical care medicine, metabolism and nutrition and is editorial board member at the Journal for Enteral and Parenteral Nutrition (JPEN). Michael enjoys travelling, walking, running, swimming or cycling with his four wonderful children and his unique, supportive and loving wife, Annelies.

Adam Deane

Adam Deane

Adam Deane, MB BS, PhD, FRACP, FCICM, is an Intensivist and currently serves as Senior Staff Specialist, Head of Intensive Care Unit Research, and Deputy Director Intensive Care Unit at The Royal Melbourne Hospital in Melbourne, Australia. He is a Principal Research Fellow in Intensive Care at The University of Melbourne. He also holds a part-time clinician Fellowship with the National Health and Medical Research Council (NHMRC). He holds honorary positions with University of Adelaide, Australia, and The George Institute for Global Health (University of NSW), Australia. From 2008 to 2016, he was an Intensivist at Royal Adelaide Hospital, Australia. His research interests are predominately clinical and include acute studies of physiology, pathophysiology and pharmacology, as well as large pragmatic multi-center trials.

Adam completed his undergraduate medical degree at the University of Melbourne. Following this, he undertook training in Internal Medicine and Intensive Care Medicine at St. Vincent's Hospital, Melbourne, Australia, and fellowships with the Royal Australian College of Physicians and College of Intensive Care Medicine, Australia. He subsequently completed a clinical fellowship in ICU at the John Radcliffe Hospital, Oxford, UK, before commencing his PhD at University of Adelaide (2007–2012).

Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.